Neurosurgeon and Pittsburgh life sciences pioneer Paul Kornblith dies at 84

Kornblith came to Pittsburgh in 1992 and served as vice chair of the department of neurosurgery at UPMC; he also founded and led Precision Therapeutics.

St. Louis Symphony Orchestra increases revenue, ticket sales in fiscal 2018

Royal Farms, Burger King closed for now in Downtown Baltimore

U-Haul prepares to present Argus Press building plans to city of Albany

Fifth Third CEO Tim Spence on bank’s commercial lending records, growth in Southeast

CBJ Morning Buzz: Charlotte Beer Garden takes No. 1 spot in national contest; AMS to lay off 115 workers here

Philadelphia restaurant openings: Garces Trading Co. debuts new location; Fishtown adds a stir-fry spot

“We cannot govern by ambush”: Boulder backs off emergency ban on building new “McMansions”

Point Ruston lender returns to court after winning $87M judgment

Neurosurgeon and Pittsburgh life sciences pioneer Paul Kornblith dies at 84

Previous 2023 outlook is slow growth and high recession risk, St. Louis Fed economist says

Next EQRx is no longer focused on 'radically' cheap drugs. Here's what it's doing instead.

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

‘Other neighborhoods have played their tune’: Why one developer is betting big on Charlotte Park

Knightsbridge Restaurant Group rebrands downtown Italian spot Bibiana

Feds, state sue to halt John Muir Health’s acquisition of San Ramon hospital

Sugar Land joins Putting Assets to Work initiative to monetize unused land

Regents sign off on ‘transformational’ KU Med project in Wichita

Rebuild of Atlanta’s Krispy Kreme owned by Shaq expected to cost over $1M

MENU

FirstStar Group

More Stories

Farewell Finn: Chase says goodbye to St. Louis-tested app aimed at younger customers

Previous 2023 outlook is slow growth and high recession risk, St. Louis Fed economist says

Next EQRx is no longer focused on 'radically' cheap drugs. Here's what it's doing instead.

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories